This synergistic combination pairs CJC-1295 without DAC, a growth hormone releasing hormone (GHRH) analog, with Ipamorelin, a selective growth hormone secretagogue, creating a complementary research profile
A recent unsupervised cluster analysis based on a broad range of circulating biomarkers found that higher levels of NT-proBNP identify a subgroup of HFpEF patients (who also shared higher levels of cardiac troponin) who are at the highest risk of death and/or HF hospitalisation (62.8% over a median follow-up of 21 months).14 In the acute setting, NT-proBNP level is also considered a strong independent predictor of all-cause mortality, as recently described in the study by Lopuszynski et al
Di Lorenzo A, Lin MI, Murata T, Landskroner-Eiger S, Schleicher M, Kothiya M, Iwakiri Y, Yu J, Huang PL, Sessa WC (2013) eNOS-derived nitric oxide regulates endothelial barrier function through VE-cadherin and Rho GTPases
The efficacy results were so impressive that an Independent Data Safety and Monitoring Board recommended the studys early termination
MEDVi's Published Statistics and Marketing Claims: What Consumers Can and Cannot Verify The MEDVi website presents several statistical claims in its marketing materials
